Following a breakthrough 'cure' for sickle cell disease being approved on the NHS, the Mirror sat down with four British ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

While both sickle cell trait and sickle cell disease involve mutations in the haemoglobin gene, they are fundamentally different in terms of symptoms, severity, and impact on daily life.

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

Sickle cell disease experts are worried that recent staffing changes at the Centers for Disease Control and Prevention will impact a program that collects data about the genetic disease and how ...

E and K antigens that can also cause transfusion reactions, especially when a person has gotten many blood transfusions. This is frequently the case in people with sickle cell disease, the vast ...

Currently, diagnosing SCD requires expensive tools like high-performance liquid chromatography (HPLC), which limits early detection in large populations.

The NHS had also reached a deal in August 2024 to provide exa-cel for eligible patients with transfusion-dependent beta-thalassaemia. Sickle cell disease is caused by a gene mutation that results in ...

which assessed the long-term trends of treatment and access to health care for people living with sickle cell disease. SCD is an inherited blood disorder that increases the risk of stroke ...

More information: Jessica Wu et al, C-reactive protein and the menstrual cycle in females with sickle cell disease, Blood Vessels, Thrombosis & Hemostasis (2025). DOI: 10.1016/j.bvth.2025.100067 ...

Scientists at Raman Research Institute (RRI) have developed an affordable electro-fluidic device that aids in preliminary screening of Sickle Cell Disease (SCD). According to RRI, the innovative ...